Home / Expertise / Intellectual Property
cut away of nautilus shell showing the beautiful spiral inside

Intellectual Property

International

In today’s knowledge economy, a large part of the value of your business is based on intangible assets and goodwill. Your intellectual property plays a key role in obtaining a competitive advantage. A cohesive IP strategy, including both commercialisation and enforcement, will ensure you get maximum value from your portfolio. With 150 specialist lawyers in 33 countries, we understand your business needs and have worked with some of the best-known brands, from banks to tech and media companies, pharmaceuticals and FMCG companies. This industry-specific approach can help you realise your commercial goals.

The right brands will win the hearts and minds of your customers. The right patents will prevent others exploiting your ideas or provide a substantial barrier to market access. Copyright, know-how and designs also play a vital role. We focus on key sectors relevant to you such as lifesciences, automotive, machinery, manufacturing, consumer products, financial services and TMC. This means you get in-depth industry knowledge as well as legal expertise for the protection of your IP. If you are involved in a dispute, we can guide you through the litigation process.

Read more Read less
June 2019
CMS In­tel­lec­tu­al Prop­erty Glob­al Bro­chure
#
Brochure
Our In­ter­na­tion­al In­tel­lec­tu­al Prop­erty Group
Con­tact De­tails
#
Brochure
CMS Ex­pert Guides
Easy ac­cess to ex­pert ad­vice that’s rel­ev­ant to you

Feed

Show only
CMS Ex­pert Guide to COV­ID-19's Im­pact on IP Leg­al Tim­ings
#
Expert Guide
#
Intellectual Property
26 May 20
European Com­mis­sion must ad­dress in­tel­lec­tu­al prop­erty and AI
The Com­mit­tee on Leg­al Af­fairs (JURI) of the European Par­lia­ment has pub­lished three draft re­ports re­lat­ing to ar­ti­fi­cial in­tel­li­gence (AI). This note is about the draft re­port on in­tel­lec­tu­al prop­erty...
#
Law-Now Life Sciences & Healthcare
31 Jan 20
Con­sumer Products News­let­ter
In­tel­lec­tu­al Prop­erty and Un­fair Com­pet­i­tion law
#
Publication Consumer Products
26 May 20
European Pat­ent Of­fice COV­ID-19 pro­vi­sions - as at 25 May 2020
The EPO has re­cently is­sued fur­ther in­form­a­tion re­gard­ing or­al pro­ceed­ings be­fore ex­am­in­a­tion and op­pos­i­tion di­vi­sions and be­fore the Boards of Ap­peal. This art­icle sum­mar­ises all of the EPO’s COV­ID-19...
#
Law-Now Intellectual Property
August 2019
How block­chain will re­volu­tion­ise the gam­ing in­dustry
#
Publication Esports and Videogames
05 May 20
European Pat­ent Of­fice (EPO) COV­ID-19 pro­vi­sions – as at 5 May 2020
The EPO has now is­sued a fur­ther guid­ance no­tice re­gard­ing its dead­lines in light of the on­go­ing coronavir­us situ­ation, which re­places the pre­vi­ous no­tice dated 16 April 2020 and which will be pub­lished...
#
Law-Now Coronavirus (COVID-19)
August 2019
Game­play on-the-move
What's next for mo­bile es­ports?
#
Publication Esports and Videogames
30 Apr 20
COV­ID-19 - EUIPO ex­tends dead­lines
The EUIPO yes­ter­day ex­ten­ded time lim­its which are due to ex­pire between Fri­day, 1 May 2020 and Sunday, 17 May 2020 to Monday, 18 May 2020. This fol­lows the earli­er ex­ten­sion of time lim­its un­til 1 May...
#
Law-Now Coronavirus (COVID-19)
August 2019
Avoid­ing ugly head­lines
Com­pli­ance in es­ports
#
Publication Esports and Videogames
27 Mar 20
Man­aging clin­ic­al tri­als un­der COV­ID-19: New EU guid­ance is­sued for...
The COV­ID-19 pan­dem­ic has had a dra­mat­ic im­pact on European health sys­tems, whose pri­or­ity first and fore­most is the treat­ment of pa­tients suf­fer­ing from this dis­ease both in the in-pa­tient and out-pa­tient...
#
Law-Now Coronavirus (COVID-19)
19 Aug 19
Big data ana­lyt­ics means big bucks for es­ports
#
Publication Esports and Videogames
19 Mar 20
Ger­man Con­sti­tu­tion­al Court to an­nounce de­cision on Uni­fied Pat­ent...
The Ger­man Fed­er­al Con­sti­tu­tion­al Court has an­nounced on its web­site that it will pub­lish its de­cision re­gard­ing the Ger­man Rat­i­fic­a­tion Act and the con­sti­tu­tion­al com­plaint against the Uni­fied Pat­ent...
#
Law-Now Intellectual Property
Load more articles